These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15072768)

  • 21. Mutagenic effects of ribavirin in vivo.
    Perelson AS; Ribeiro RM
    J Hepatol; 2005 Oct; 43(4):553-5. PubMed ID: 16099528
    [No Abstract]   [Full Text] [Related]  

  • 22. Convert hepatitis C virus into a non-enveloped virus like hepatitis A, by targeting its envelope rather than the RNA.
    Helmy A
    Med Hypotheses; 2006; 66(4):847-50. PubMed ID: 16229965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Error-prone replication of West Nile virus caused by ribavirin.
    Day CW; Smee DF; Julander JG; Yamshchikov VF; Sidwell RW; Morrey JD
    Antiviral Res; 2005 Jul; 67(1):38-45. PubMed ID: 15919121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral effect of ribonuclease conjugated oligodeoxynucleotides targeting the IRES RNA of the hepatitis C virus.
    Gamble C; Trotard M; Le Seyec J; Abreu-Guerniou V; Gernigon N; Berrée F; Carboni B; Felden B; Gillet R
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3581-5. PubMed ID: 19450979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity.
    Hadj Hassine I; Ben M'hadheb M; Menéndez-Arias L
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges for the development of ribonucleoside analogues as inducers of error catastrophe.
    Graci JD; Cameron CE
    Antivir Chem Chemother; 2004 Jan; 15(1):1-13. PubMed ID: 15074710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral Strategies Based on Lethal Mutagenesis and Error Threshold.
    Perales C; Domingo E
    Curr Top Microbiol Immunol; 2016; 392():323-39. PubMed ID: 26294225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The increasing impact of lethal mutagenesis of viruses.
    Perales C; Gallego I; de Ávila AI; Soria ME; Gregori J; Quer J; Domingo E
    Future Med Chem; 2019 Jul; 11(13):1645-1657. PubMed ID: 31469331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanisms of the effect of antiviral agents].
    Holý A
    Cas Lek Cesk; 1993 Jan; 132(1):12-7. PubMed ID: 8435843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral membranes: an emerging antiviral target for enveloped viruses?
    Song JM; Seong BL
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):635-8. PubMed ID: 20521891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theories of Lethal Mutagenesis: From Error Catastrophe to Lethal Defection.
    Tejero H; Montero F; Nuño JC
    Curr Top Microbiol Immunol; 2016; 392():161-79. PubMed ID: 26210988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theory of lethal mutagenesis for viruses.
    Bull JJ; Sanjuán R; Wilke CO
    J Virol; 2007 Mar; 81(6):2930-9. PubMed ID: 17202214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future prospects for the treatment of rapidly evolving viral pathogens: insights from evolutionary biology.
    Domingo E; Grande-Pérez A; Martín V
    Expert Opin Biol Ther; 2008 Oct; 8(10):1455-60. PubMed ID: 18774914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [N,NL-MALONYL-BIS-ETHYLENIMINE AND ITS VARIOUS BIOLOGICAL PROPERTIES].
    BORISOV LB; BEILIN VG; DASHKEVICH LB; IAKOVLEVA GS
    Biull Eksp Biol Med; 1963 Jun; 55():76-9. PubMed ID: 14070884
    [No Abstract]   [Full Text] [Related]  

  • 36. Molnupiravir's mechanism of action drives "error catastrophe" in SARS-CoV-2: A therapeutic strategy that leads to lethal mutagenesis of the virus.
    Chatterjee S; Bhattacharya M; Dhama K; Lee SS; Chakraborty C
    Mol Ther Nucleic Acids; 2023 Sep; 33():49-52. PubMed ID: 37397276
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobials: Broad-spectrum antivirals.
    Edagwa BJ; Gendelman HE
    Nat Mater; 2018 Jan; 17(2):114-116. PubMed ID: 29358769
    [No Abstract]   [Full Text] [Related]  

  • 38. Broad-spectrum antivirals.
    Edagwa BJ; Gendelman HE
    Nat Mater; 2018 Feb; 17(2):114-116. PubMed ID: 31745273
    [No Abstract]   [Full Text] [Related]  

  • 39. Small molecules in the treatment of COVID-19.
    Lei S; Chen X; Wu J; Duan X; Men K
    Signal Transduct Target Ther; 2022 Dec; 7(1):387. PubMed ID: 36464706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-d-
    Urakova N; Kuznetsova V; Crossman DK; Sokratian A; Guthrie DB; Kolykhalov AA; Lockwood MA; Natchus MG; Crowley MR; Painter GR; Frolova EI; Frolov I
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29167335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.